Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000080.xml
Download PDF
Sleep Breath 2003; 07(2): 053-062
DOI: 10.1055/s-2003-40663
DOI: 10.1055/s-2003-40663
Nitric Oxide (NO) and Obstructive Sleep Apnea (OSA)
Further Information
Publication History
Publication Date:
14 July 2003 (online)
ABSTRACT
Nitric oxide (NO) and obstructive sleep apnea are inseparable. Obstructive sleep apnea could be described as the intermittent failure to transport the full complement of nasal NO to the lung with each breath. There NO matches perfusion to ventilation. NO is utilized by the efferent pathways that control the unequal, inspiratory battle between the pharyngeal dilators and the closing negative pressures induced by the thoracic musculature. Recurrent cortical arousals are a major short-term complication, and the return to sleep after each arousal uses NO. The long-term complications, namely hypertension, myocardial infarction, and stroke, might be due to the repeated temporary dearth of NO in the tissues, secondary to a lack of oxygen, one of NO's two essential substrates.
KEYWORDS
Nitric oxide - sleep apnea - sleep-disordered breathing - airway obstruction - hypoxia - arousals
REFERENCES
- 1 Kula S, Remmers J E. Anatomy and physiology of upper airway obstruction. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine Philadelphia, PA: WB Saunders 2000: 840-858
MissingFormLabel
- 2 Krueger J M, Obal Jr F, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci . 2001; 933 211-221
- 3 Djupesland P G, Chatkin J M, Qian W, Haight J SJ. Nitric oxide in the nasal airway: a new dimension to otorhinolaryngology. Am J Otolaryngol Head Neck Surg . 2002; 22 19-32
- 4 Antonin I, Mayo, J C, Sainz R M. et al . Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res . 2002; 943 163-173
- 5 Cespuglio R, Burlet S, Faradji-Prevautel H. 5-Hydroxy indole compounds and nitric oxide volumetric detection in the rat brain: changes occurring throughout the sleep-wake cycle. J Neural Transm . 1998; 105(2-3) 205-215
- 6 Pokk P, Vali M. The effect of the nitric oxide synthase inhibitors on the behaviour of the small-platform-stressed mice in the plus-maze test. Prog Neuropsychopharmacol Biol Psychiatry . 2002; 26 241-247
- 7 Qian W, Djupesland P G, Haight J SJ. Unpublished data: 2000.
MissingFormLabel
- 8 Osanai S, Ide H, Yamamoto Y, Nakano H, Kikuchi K. Nitric oxide in sleep apneics Japanese. J Clin Med . 2000; 58 1665-1670
- 9 Agusti A G, Barbe F, Togores B. Exhaled nitric oxide in patients with sleep apnea. Sleep . 1999; 22 231-235
- 10 Haight J SJ, Djupesland P G, Qian W. et al . Does nasal nitric oxide come from the sinuses?. J Otolaryngol . 1999; 28 197-204
- 11 Stamler J S, Loh E, Roddy M A. et al . Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation . 1994; 89 2035-2040
- 12 Blitzer M L, Loh E, Roddy M A. et al . Endothelium derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol . 1996; 28 591-596
- 13 Lundberg J O, Settergren G, Gelinder S, Lundberg J M, Alving K, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand . 1996; 158 343-347
- 14 Djupesland P G, Chatkin J M, Qian W. et al . Aerodynamic influences on nasal nitric oxide output measurements. Acta Otolaryngol . 1999; 119 479-485
- 15 Cole P. Stability of nasal airflow resistance. Clin Otolaryngol Allied Sci . 1989; 14 177-182
- 16 Cole P, Haight J SJ. Posture and the nasal cycle. Ann Otol Rhinol Laryngol . 1986; 95 233-234
- 17 Cole P, Haight J SJ. Posture and nasal patency. Am Rev Respir Dis . 1984; 129 351-354
- 18 Haight J SJ, Cole P. Topographic anatomy of the pressure points that alter nasal resistance. J Otolaryngol . 1986; 15(suppl 16) S14
- 19 Qian W, Sabo R, Ohm M, Haight J SJ, Fenton R. Nasal nitric oxide and the nasal cycle. Laryngoscope . 2001; 111 1603-1607
- 20 McNicholas W T, Tarlo S, Cole P. Obstructive sleep apnea during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis . 1982; 126 625-628
- 21 Leznoff A, Haight J SJ, Hoffstein V. Reversible obstructive sleep apnea due to occupational exposure to guar gum dust. Am Rev Respir Dis . 1986; 133 935-936
- 22 Djupesland P G, Skatvedt O, Borgersen A K. Dichotomous physiological effects of nocturnal external nasal dilation in heavy snorers: the answer to a rhinologic controversy?. Am J Rhinol . 2001; 15 95-103
- 23 Miljeteig H, Savard P, Mateika S, Cole P, Haight J SJ, Hoffstein V. Snoring and nasal resistance during sleep. Laryngoscope . 1993; 103 918-923
- 24 Cannon 3rd O R, Schechter A N, Panza J A. et al . Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest . 2001; 108 279-287
- 25 Rossaint R, Falke K J, Lopez F, Slama K, Pison U, Zapol W M. Inhaled nitric oxide for adult respiratory distress syndrome [comment]. N Engl J Med . 1993; 328 399-405
- 26 Klinger J R. Inhaled nitric oxide in ARDS. Crit Care Clin . 2002; 18 45-68
- 27 Singh S, Evans T W. Nitric oxide the biological mediator of the decade: fact or fiction?. Euro Respir J . 1997; 10 699-707
- 28 Jia L, Bonaventura C, Bonaventura J, Stamler J S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature . 1996; 380 221-226
- 29 Stamler J S, Jia L, Eu J P. et al . Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science . 1999; 276 2034-2037
- 30 Rassaf T, Preik M, Kleinbongard P. et al . Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest . 2002; 109 1241-1248
- 31 Myers J L, Wizorek J J, Myers A K. et al . Maturation alters the pulmonary arterial response to hypoxia and inhaled nitric oxide in the presence of endothelial dysfunction. J Thorac Cardiovasc Surg . 1997; 113 270-277
- 32 Kobzik L, Reid M B, Bredt D S, Stamler J S. Nitric oxide in skeletal muscle. Nature . 1994; 372 546-548
- 33 Murrant C L, Woodley N E, Barclay J K. Effect of nitroprusside and endothelium derived products on slow-twitch skeletal muscle function in vitro. Can J Physiol Pharmacol . 1994; 72 1089-1093
- 34 Morrison R J, Miller III C C, Reid M B. Nitric oxide effects on shortening velocity and power production in the rat diaphragm. J Appl Physiol . 1996; 80 1065-1069
- 35 Morrison R J, Miller III C C, Reid M B. Nitric oxide effects on force-velocity characteristics of the rat diaphragm. Comp Biochem Physiol . 1998; 119 203-209
- 36 Gath I, Closs E I, Godtel-Armbrust U. et al . Expressed in different structures of guinea-pig skeletal muscle: implications for contractile function. FASEB J . 1996; 10 1614-1620
- 37 Reid M B. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand . 1998; 162 401-409
- 38 Marshall J M. Roles of adenosine and nitric oxide in skeletal muscle in acute and chronic hypoxia. Adv Exp Med Biol . 2001; 502 349-363
- 39 Fitts R H, Balog E M. Effect of intracellular and extracellular ion changes on E-C coupling and skeletal muscle fatigue. Acta Physiol Scand . 1996; 156 169-181
- 40 Bruton J D, Lannergren J, Westerblad H. Mechanisms underlying the slow recovery of force after fatigue: importance of intracellular calcium. Acta Physiol Scand . 1998; 162 285-293
- 41 Gutierrez C, Qian W, Kendall C, Zamel N, Jenkins D, Haight J SJ. Effect of dietary arginine on exhaled and nasal nitric oxide. Am J Respir Crit Care Med . 2000; 161 A744
- 42 Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol . 2001; 64 365-391
- 43 Blanchard A R, Chaudhary B A. Neuropharmacology of sleep and wakefulness. In: Lee-Chiong TL, Sateira MJ, Carskadon MA eds. Sleep Medicine Philadelphia, PA; Hanley & Belfus Inc; 2002: 565-574
MissingFormLabel
- 44 Leonard T O, Lydic R. Pontine nitric oxide modulates acetylcholine release rapid eye movement sleep generation and respiratory rate. J Neurosci . 1997; 17 774-785
- 45 Seigel J M. Brainstem mechanisms generating REM sleep. In: Kryger M, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine Philadelphia, PA: WB Saunders; 2000: 112-133
MissingFormLabel
- 46 Lai Y Y, Seigel J M. Medullary regions mediating atonia. J Neurosci . 1988; 8 4790-4796
- 47 Datta S, Patterson E H, Siwek D F. Endogenous and exogenous nitric oxide in the pedunculo-pontine tegmentum induces sleep. Synapse . 1997; 27 69-78
- 48 Lai Y Y, Seigel J M. Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation. J Neurosci . 1990; 10 2727-2738
- 49 Lai Y Y, Seigel J M. Ponto-medullary glutamate receptors mediating locomotion and muscle tone suppression. J Neurosci . 1991; 11 2931-2937
- 50 Prast H, Tran M H, Fischer H, Philippu A. Nitric oxide induced release of acetycholine in the nucleus accumbens: role of cyclic GMP, glutamate and GABA. J Neurochem . 1998; 71 266-273
- 51 Kimura T, Yu J G, Edvinsson L, Lee T JF. Cholinergic nitric oxide innervation in cerebral arteries of the cat. Brain Res . 1997; 773 117-124
- 52 Bach-y-Rita P. Nonsynaptic diffusion neurotransmission (NDN) in the brain. Neurochem Int . 1993; 23 297-318
- 53 Liu X, Miller M J, Joshi M S, Sadowska-Krowicka H, Clark D A, Lancaster Jr R J. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem . 1998; 273 18709-18713
- 54 Krueger J M, Obal Jr F, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci . 2001; 933 211-221
- 55 Sippel J M, Giraud G D, Holden W E. Nasal administration of the nitric oxide synthase inhibitor L-NAME induces daytime somnolence. Sleep . 1999; 22 786-788
- 56 Cespuglio R, Burlet S, Marinesco S, Robert F, Jouvet M. Volumetric detection of cerebral NO in rats. Variations of the signal throughout the sleep-wakefulness cycle. C R Acad Sci III . 1996; 319 191-200
- 57 Kato M, Roberts, Thomson P. et al . Impairment of endothelium dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation . 2000; 102 2607-2610
- 58 Shepard Jr W J, Garrison M W, Grither D A. et al . Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am J Med . 1995; 78 28-34
- 59 Butkov N. Atlas of Clinical Polysomngraphy. Synapse Media Inc; 1996
MissingFormLabel
- 60 Haight J SJ, Qian W. Hypoxia depresses nitric oxide output in the human nasal airway. Laryngoscope . 2000; 110 429-433
- 61 Duchna H W, Guilleminault C, Stoohs R A. et al . Obstructive sleep apnea syndrome: a cardiovascular risk factor?. Zschr Kardiol . 2001; 90 568-575
- 62 Ip M S, Lam B, Chan L Y. et al . Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care . 2000; 162 2166-2171
- 63 Schulz R, Schmidt D, Blum A. et al . Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax . 2000; 55 1046-1051
- 64 McQuillan L P, Leung G K, Marsden P A, Kostyk S K, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and post-transcriptional mechanisms. Am J Physiol . 1994; 267(5 Pt 2) H1921-1927
- 65 Carlson J, Hedner J, Pettersson A. Increased plasma concentration of ADMA, a naturally occurring nitric oxide synthesis inhibitor, in OSA patients. Am J Respir Crit Care . 1997; 155 A869
- 66 Schulz R, Seeger W, Grimminger F. Serum nitrite/nitrate levels in obstructive sleep apnea [letter]. Am J Respir Crit Care . 2000; 164 1997-1998
- 67 Lavery C E, Mittleman M A, Cohen M C. et al . No uniform nighttime distribution of acute cardiac events. A possible effect of sleep states. Circulation . 1997; 96 3321-3327
- 68 Muller J G, Tofler G H, Stone P H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation . 1989; 79 733-743
- 69 Rossi G B, Seccia T M, Nussdorfer G G. Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int Rev Cytol . 2001; 209 241-272
- 70 Gewaltig M T, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res . 2002; 55 250-260
- 71 Hung J, Withford E G, Parsons R W, Hillman D R. Association of sleep apnea with myocardial infarction in men. Lancet . 1990; 336 261-264
- 72 Koskenvuo M, Kaprio J, Telakivi T. et al . Snoring as a risk factor for ischemic heart disease and stroke in men. Br Med J . 1987; 294 16-19
- 73 Ross R. Mechanisms of disease-atheroslerosis-an inflammatory disease. N Engl J Med . 1999; 340 115-126
- 74 Schwartz S M. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest . 1997; 99 2814-2817
- 75 Scott-Burden T, Vanhoutte P M. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation . 1993; 87 (suppl 5) S51-S55
- 76 Nakaki T, Nakayama M, Kato R. Inhibition of nitric oxide and nitric oxide producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol Mol Pharmacol . 1990; 189 347-353
- 77 Bolli R. Cardioprotective function of inducible nitric oxide synthesis and role of nitric oxide in myocardial ischaemia and preconditioning: an overview of a decade research. J Mol Cell Cardiol . 2001; 33 1897-1918
- 78 Brooks D, Horner R L, Kozar L F. et al . Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest . 1997; 99 106-109
- 79 Brooks D, Horner R L, Kimoff L F. et al . Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med . 1997; 155 1609-1617
- 80 Young T, Peppard P, Palta M. et al . Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med . 1997; 157 1746-1752
- 81 Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. Br Med J . 2000; 320 479-482
- 82 Huang P L, Huang Z H, Mashimo H. et al . Hypertension in mice lacking the egene for endothelial nitric oxide synthase. Nature . 1995; 377 239-242
- 83 Kunsch C, Medford R M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res . 1999; 85 753-766
- 84 Kojda G, Harrison D G. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res . 1999; 43 562-571
- 85 Massberg S, Sausbier M, Klatt P. et al . Increased adhesion and aggregation of platelets lacking cyclic guanosine 3'-5'-monophosphate kinase I. J Exp Med . 1999; 189 1255-1263
- 86 Kubes P, Suzuki M, Granger D N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A . 1991; 88 4651-4655